Delivery Order SPE2DB22D2009-SPE2DB24FM0VG

Award Date 7/13/24
Potential Completion Date 7/15/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,854.04 firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The award has a completion date of July 22, 2024. Amerisourcebergen holds a larger indefinite delivery contract with the DLA Troop Support Medical valued up to $999,999,999 through December...
This is a $21,289.11 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of November 22, 2023. This delivery order is issued under AmerisourceBergen's larger...
This is a $14,531.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a completion date of December 18, 2023 and was awarded on December 15, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a $28,829.27 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $5,034.24 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Trulicity 4.5 mg/0.5 ml pens, a medication used to treat diabetes. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and...
This is a $1,201.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for Trulicity 1.5 mg/0.5 ml pens, a diabetes medication. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle...
This is a $2,493.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 4.5 mg/0.5 ml pens, a medication used for diabetes management. The order has an ultimate completion date of October 22, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a large $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to...
This is a $1,015.98 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a prescription diabetes medication. This delivery order is part of a larger indefinite delivery contract awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 through December 31, 2025. The contract does not have...
This is a $2,476.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat Type 2 diabetes. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $3,773.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM0VG
    Delivery Order

This is a $7,578.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 4.5 mg/0.5 mL pens, a medication used to treat type 2 diabetes. The order has a completion date of July 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition. The contract supports the DLA's role in supplying medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/17/25, 10:04 AM